Professor of Medicine
Director, Interventional Cardiology
Stanford University School of Medicine
Stanford, California, United States
Dr. Fearon is currently a Professor of Medicine (Cardiology) and Director of Interventional Cardiology at Stanford University School of Medicine and Chief of Cardiology at the Palo Alto VA Healthcare System. Dr. Fearon’s primary area of research interest is in coronary physiology. He has been the principal investigator of numerous multicenter clinical trials, including the FAME trials, which have resulted in multiple publications in the New England Journal of Medicine and led to worldwide adoption of the use of coronary physiology to guide revascularization decisions in the cardiac catheterization laboratory. He also derived and validated the index of microcirculatory resistance, which is now used commonly to assess coronary microvascular function in the cath lab. Dr. Fearon’s clinical activities include not only percutaneous coronary intervention, but also transcatheter aortic valve replacement.
Disclosure information not submitted.
Coronary, Physiology and CMD [Non-CME]
Saturday, March 9, 2024
8:00 AM – 12:11 PM ET
Live Case from St. Francis Hospital, Roslyn, NY
Saturday, March 9, 2024
8:32 AM – 9:25 AM ET
Saturday, March 9, 2024
9:25 AM – 9:33 AM ET
Saturday, March 9, 2024
10:29 AM – 10:36 AM ET
How to Assess Microvascular Function: Tips and Tricks I
Saturday, March 9, 2024
10:52 AM – 11:00 AM ET
Moderated Discussion: Coronary Microvascular Dysfunction
Saturday, March 9, 2024
11:56 AM – 12:11 PM ET
Late-Breaking Clinical Science | Intravascular Imaging / Physiology [Non-CME]
Saturday, March 9, 2024
3:15 PM – 4:30 PM ET
CARDIOTUBE INTERVIEW - When to perform CMD and how to treat it
Sunday, March 10, 2024
1:15 PM – 1:30 PM ET